GSK Is Breathing Easier On Advair Labeling, Expects Sales To Rebound
GlaxoSmithKline has increased the number of sales reps behind the long-acting beta antagonist to correct "labeling misperceptions."
GlaxoSmithKline has increased the number of sales reps behind the long-acting beta antagonist to correct "labeling misperceptions."